Researcher charged in major HIV vaccine fraud case

by Ryan J. Foley

Responding to a major case of research misconduct, federal prosecutors are taking a rare step by charging a scientist with fraud after he admitted falsifying data while researching an HIV vaccine.

Authorities say former Iowa State University laboratory manager Dong-Pyou Han has confessed to manipulating data that helped his team get millions in grants and increased hopes of a major breakthrough in AIDS research.

Experts say the was particularly brazen, and charges are rarely brought in part because less money is usually involved. The National Institutes of Health is reviewing the case's impact on research it funds.

Han resigned from the university last fall. He was indicted last week and could face prison time if convicted. He's free on bond but didn't respond to a message seeking comment Tuesday.

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Court sides with US in cell-tracking records case (Update)

May 09, 2014

The Justice Department does not have to turn over information on cases involving warrantless cellphone tracking if the cases ended without a defendant's conviction, a divided U.S. appeals court ruled Friday in upholding privacy ...

UK researcher sentenced to three months' jail for faking data

Apr 19, 2013

A British scientist convicted of scientific fraud last month for falsifying research data has been sentenced to three months jail. Steven Eaton is the first person to serve time under the UK's Good Laboratory Practice Regulations, 1999. ...

Recommended for you

FDA warning: men's testosterone drugs overused (Update)

Mar 03, 2015

The Food and Drug Administration is warning doctors against over-prescribing testosterone-boosting drugs for men, saying the popular treatments have not been established as safe or effective for common age-related ...

Early benefit assessment increases transparency for study data

Mar 03, 2015

Four years have passed since the introduction of the German Act on the Reform of the Market for Medicinal Products (AMNOG). AMNOG was primarily aimed at containing the increasing drug expenditure of the statutory health insurance ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.